Author Correction: Engineering-enhanced CAR T cells for improved cancer therapy

Michael C Milone^{1

2}, Jie Xu^{1

2

3}, Sai-Juan Chen³, McKensie A Collins^{1

2}, Jianfeng Zhou⁴, Daniel J Powell Jr^{1

2}, J Joseph Melenhorst^{5

6}

Affiliations

¹ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
⁴ Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Tianjin, People's Republic of China.
⁵ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.
⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.

Published Erratum

Michael C Milone et al. Nat Cancer. 2021 Oct.

. 2021 Oct;2(10):1113.

doi: 10.1038/s43018-021-00277-7.

Michael C Milone^{1

2}, Jie Xu^{1

2

3}, Sai-Juan Chen³, McKensie A Collins^{1

2}, Jianfeng Zhou⁴, Daniel J Powell Jr^{1

2}, J Joseph Melenhorst^{5

6}

¹ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
⁴ Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Tianjin, People's Republic of China.
⁵ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.
⁶ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.

No abstract available

Erratum for

Engineering enhanced CAR T-cells for improved cancer therapy.
Milone MC, Xu J, Chen SJ, Collins MA, Zhou J, Powell DJ Jr, Melenhorst JJ. Milone MC, et al. Nat Cancer. 2021 Aug;2(8):780-793. doi: 10.1038/s43018-021-00241-5. Epub 2021 Aug 19. Nat Cancer. 2021. PMID: 34485921 Free PMC article. Review.